What Are The Research Benefits of Sermorelin
Stimulation of Growth Hormone Production: It is a GHRH analogue that stimulates the secretion of growth hormone from the pituitary gland. Research, including a study by Molitch et al. (2018), shows its effectiveness in boosting GH levels, supporting growth, metabolism, and overall health.
Anti-Aging Properties: GH decline is a hallmark of aging. The peptide’s ability to rejuvenate GH levels has led to its recognition as an anti-aging agent. Greece Studies have indicated its potential in mitigating age-related issues such as muscle wasting, cognitive decline, and decreased vitality (2).
Improved Muscle Mass and Strength: GH plays a pivotal role in muscle growth and repair. Greece Research suggests supplementation has been linked to increased muscle mass and strength, making it a valuable asset in the realm of sports medicine and rehabilitation (2).
Enhanced Exercise Performance: Studies indicate that it’s ability to boost GH levels contributes to improved exercise capacity, endurance, and overall physical performance. Athletes and fitness enthusiasts often use sermorelin to optimize their training outcomes (3).
Accelerated Fat Metabolism: GH facilitates the breakdown of fats and their conversion into energy. Greece Studies suggest it aids in fat metabolism, leading to reduced adiposity and a more favorable body composition (4).
Support for Bone Health: GH is essential for bone remodeling and maintenance. Greece Studies suggest it may promote bone density and reduce the risk of osteoporosis, especially in aging populations (5).
Enhanced Cognitive Function: GH receptors are abundantly present in the brain, indicating a significant role in cognitive function. Research suggests it has been associated with improved memory, mental clarity, and overall cognitive performance, as evidenced by research studies (6).
Cardiovascular Health: GH has cardio-protective effects, including the regulation of blood pressure and lipid metabolism (7). Research has been shown it to support cardiovascular health, reducing the risk factors associated with heart diseases.
Regulated Sleep Patterns: GH influences sleep quality and the regulation of circadian rhythms. Greece Studies indicate it could be linked to improved sleep patterns and a sense of restfulness, which are vital for overall well-being (8).
One study examined the effects of growth hormone secretagogues (GHSs) on the somatotropic axis in rainbow trout, with a focus on growth hormone (GH), IGF-I, IGF-binding proteins (IGFBPs), and additional factors such as orexin secretion and its implications in sleep disorders. GHS treatments not only increased feed intake and plasma GH levels but also influenced the secretion and timing of key hormones integral to growth hormone secretion (9).
Epilepsy research: It has been shown that GABA is a key compound in the central nervous system, reducing excitability and helping to control seizures. Growth hormone releasing hormone (GHRH) increases GABA levels and activates GABA receptors (GABARs), potentially reducing abnormal electrical activity linked to seizures. Elevated GHRH expression was observed in epilepsy patients and mouse models compared to normal groups.
GHRH was found in neurons and co-localised with inhibitory synapses, interacting with GABAAα1 and GABAAβ2+3 receptors. Research on epileptic mice shows that GHRH analogues, like sermorelin, can suppress seizures by enhancing GABA’s effects, offering potential for safer treatments with fewer side effects (10).
Buy Sermorelin peptide vial Greece for laboratory research purposes online today! Available as lyophilized powder in 2 mg and 5 mg vials. Before use, it is important to reconstitute the peptide with bacteriostatic water.
References For Further Reading
(1) Mark E Molitch, David R Clemmons, Saul Malozowski, George R Merriam, and Mary Lee Vance (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline – Journal of Clinical Endocrinology & Metabolism, 2011 Jun, Volume 96 (Issue 6), Pages 1587-609.
(2) Richard F Walker (2006) Sermorelin: A better approach to management of adult-onset growth hormone insufficiency? – Clinical Interventions in Aging, 2006 Dec, Volume 1 (Issue 4), Pages 307–308.
(3) Richard J Godfrey, Zahra Madgwick, and Gregory P Whyte (2003) The exercise-induced growth hormone response in athletes – Sports Medicine, 2003, Volume 33 (Issue 8), Pages 599-613.
(4) Valéria Ernestânia Chaves, Fernando Mesquita Júnior, and Gisele Lopes Bertolini (2013) The metabolic effects of growth hormone in adipose tissue – Endocrine, 2013 Oct, Volume 44 (Issue 2), Pages 293-302.
(5) Maya Barake, Asma Arabi, Nancy Nakhoul, Ghada El-Hajj Fuleihan, et al (2018) Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis – Endocrine, 2018 Jan, Volume 59 (Issue 1), Pages 39-49.
(6) Brian V Lananna and Erik S Musiek (2021) The wrinkling of time: Aging, inflammation, oxidative stress, and the circadian clock in neurodegeneration – Neurobiology of Disease, 2020 Mar 13, Volume 139, Page 104832.
(7) Rosemeire M Kanashiro-Takeuchi, Luca Szalontay, Andrew V Schally, Lauro M Takeuchi, et al (2015) New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor – Oncotarget, 2015, Volume 6 (Issue 12), Pages 9728-39.
(8) Michael V Vitiello, Robert S Schwartz, Karen E Moe, Giuliana Mazzoni, and George R Merriam (2001) Treating age-related changes in somatotrophic hormones, sleep, and cognition – Dialogues in Clinical Neuroscience, 2001 Sep, Volume 3 (Issue 3), Pages 229–236.
(9) Brian S Shepherd, Jaime K Johnson, Jeffrey T Silverstein, Ishwar S Parhar, et al (2007) Endocrine and orexigenic actions of growth hormone secretagogues in rainbow trout (Oncorhynchus mykiss) – Comparative Biochemistry and Physiology: A Molecular & Integrative Physiology, 2007 Mar, Volume 146 (Issue 3), Pages 390-9.
(10) Shirong Tang, Zhong Luo, Xiaowei Qiu, Yanke Zhang, et al (2017) Interactions between GHRH and GABAARs in the brains of patients with epilepsy and in animal models of epilepsy – Scientific Reports, 2017 Dec 22, Volume 7 (Issue 1), Pages 18110.